Toronto Dominion Bank’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.95M Sell
43,371
-5,802
-12% -$1.07M 0.01% 699
2025
Q4
$8.65M Sell
49,173
-9,811
-17% -$1.6M 0.01% 681
2025
Q3
$8.26M Sell
58,984
-7,933
-12% -$1.07M 0.01% 676
2025
Q2
$8.4M Buy
66,917
+11,274
+20% +$1.4M 0.01% 627
2025
Q1
$7.61M Sell
55,643
-17,028
-23% -$2.43M 0.01% 573
2024
Q4
$11.1M Buy
72,671
+12,301
+20% +$2.07M 0.02% 500
2024
Q3
$11.7M Sell
60,370
-22,878
-27% -$4.79M 0.02% 428
2024
Q2
$19.3M Sell
83,248
-12,436
-13% -$2.7M 0.03% 322
2024
Q1
$20.6M Buy
95,684
+3,444
+4% +$807K 0.03% 331
2023
Q4
$23.9M Buy
92,240
+1,164
+1% +$286K 0.03% 328
2023
Q3
$23.4M Sell
91,076
-5,762
-6% -$1.54M 0.04% 305
2023
Q2
$27.6M Buy
96,838
+1,212
+1% +$361K 0.04% 296
2023
Q1
$26.6M Sell
95,626
-40,487
-30% -$11.2M 0.04% 265
2022
Q4
$37.7M Buy
136,113
+56,845
+72% +$16.1M 0.06% 219
2022
Q3
$21.1M Sell
79,268
-14,592
-16% -$3.1M 0.04% 297
2022
Q2
$19.1M Sell
93,860
-8,038
-8% -$1.64M 0.04% 274
2022
Q1
$21.5M Sell
101,898
-17,369
-15% -$3.78M 0.03% 279
2021
Q4
$28.6M Buy
119,267
+10,743
+10% +$2.76M 0.04% 269
2021
Q3
$30.7M Buy
108,524
+21,991
+25% +$7.21M 0.05% 215
2021
Q2
$30M Buy
86,533
+644
+0.7% +$195K 0.05% 233
2021
Q1
$24M Sell
85,889
-18,098
-17% -$4.88M 0.04% 245
2020
Q4
$25.5M Buy
103,987
+6,506
+7% +$1.68M 0.05% 231
2020
Q3
$27.7M Sell
97,481
-17,462
-15% -$4.87M 0.07% 184
2020
Q2
$30.8M Sell
114,943
-24,312
-17% -$7.31M 0.08% 172
2020
Q1
$44.1M Sell
139,255
-34,479
-20% -$10.5M 0.13% 127
2019
Q4
$51.5M Buy
173,734
+29,336
+20% +$8.14M 0.09% 153
2019
Q3
$33.6M Sell
144,398
-145,658
-50% -$33.9M 0.07% 190
2019
Q2
$33.9M Buy
290,056
+142,441
+96% +$32.9M 0.07% 184
2019
Q1
$34.9M Buy
147,615
+23,821
+19% +$7.5M 0.05% 194
2018
Q4
$37.2M Sell
123,794
-11,514
-9% -$3.67M 0.06% 153
2018
Q3
$47.8M Sell
135,308
-514
-0.4% -$177K 0.09% 142
2018
Q2
$39.4M Buy
135,822
+21,664
+19% +$6.09M 0.08% 162
2018
Q1
$31.3M Buy
114,158
+21,464
+23% +$6.66M 0.07% 161
2017
Q4
$29.5M Buy
92,694
+12,280
+15% +$3.94M 0.09% 147
2017
Q3
$25.2M Buy
80,414
+7,899
+11% +$2.34M 0.08% 148
2017
Q2
$19.7M Buy
72,515
+14,114
+24% +$3.73M 0.06% 180
2017
Q1
$16M Buy
58,401
+20,747
+55% +$5.87M 0.04% 189
2016
Q4
$10.7M Buy
37,654
+31,135
+478% +$9.23M 0.03% 189
2016
Q3
$2.04M Buy
6,519
+5,257
+417% +$1.56M 0.01% 305
2016
Q2
$306K Sell
1,262
-450
-26% -$119K ﹤0.01% 509
2016
Q1
$446K Sell
1,712
-5,421
-76% -$1.43M ﹤0.01% 404
2015
Q4
$2.19M Sell
7,133
-150,655
-95% -$43.3M 0.01% 231
2015
Q3
$46M Buy
157,788
+1,298
+0.8% +$429K 0.26% 54
2015
Q2
$63.2M Buy
156,490
+37
+0% +$14.8K 0.3% 53
2015
Q1
$66.1M Buy
156,453
+146,710
+1,506% +$57.8M 0.28% 53
2014
Q4
$3.31M Buy
9,743
+5,285
+119% +$1.71M 0.01% 232
2014
Q3
$1.48M Sell
4,458
-117
-3% -$38.6K 0.01% 304
2014
Q2
$1.44M Buy
4,575
+801
+21% +$241K ﹤0.01% 324
2014
Q1
$1.15M Buy
3,774
+4
+0.1% +$1.27K ﹤0.01% 341
2013
Q4
$1.05M Buy
+3,770
New +$975K ﹤0.01% 339

Other funds holding BIIB

Toronto Dominion Bank's BIIB Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Biogen (BIIB) stake by 12% in Q1 2026, selling an estimated $1.07M and leaving 43,371 shares worth $7.95M. The position accounts for 0.01% of the portfolio, ranked #699.

Toronto Dominion Bank first reported a position in BIIB in Q4 2013 and has held it in 50 quarters since. The position peaked at $66.1M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Toronto Dominion Bank held 43,371 shares of Biogen worth $7.95M as of Q1 2026.
  • Toronto Dominion Bank sold 5,802 Biogen shares in Q1 2026, an estimated $1.07M.
  • Biogen made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #699 holding.
  • Toronto Dominion Bank first reported a position in Biogen in Q4 2013 and has held it in 50 quarters since.
  • Toronto Dominion Bank's Biogen position peaked at $66.1M in Q1 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.